Akari Therapeutics (AKTX) Change in Intangibles (2015 - 2023)
Akari Therapeutics recorded quarterly Change in Intangibles of $15779.0 in Q2 2023, down 6.52% quarter-over-quarter from $16880.0 in Q4 2022, and down 16.27% year-over-year from $18844.0 in Q2 2022.
Akari Therapeutics' Change in Intangibles history runs 9 years deep, the most recent figure standing at $15779.0 for Q2 2023.
- In Q2 2023, Change in Intangibles fell 16.27% year-over-year to $15779.0; the TTM figure through Jun 2023 stood at $15779.0 (down 16.27% YoY), while the FY2022 annual figure was $16880.0, down 26.38% from the prior year.
- Change in Intangibles came in at $15779.0 for Q2 2023 at Akari Therapeutics, down from $16880.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $32867.0 in Q1 2019 to a low of $15779.0 in Q2 2023.
- A 5-year average of $25044.7 and a median of $26460.0 in 2021 frame the typical range for Change in Intangibles.
- Across the five-year window, Change in Intangibles slipped 3.56% in 2021 and retreated 26.38% in 2022, its largest moves.
- Akari Therapeutics' Change in Intangibles stood at $30163.0 in 2019, then dropped by 11.57% to $26674.0 in 2020, then decreased by 14.04% to $22929.0 in 2021, then declined by 26.38% to $16880.0 in 2022, then decreased by 6.52% to $15779.0 in 2023.
- According to Business Quant data, Change in Intangibles over the past three periods registered $15779.0, $16880.0, and $18844.0 for Q2 2023, Q4 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 15,779.00 |
| Jun 30, 2023 | 15,779.00 |
| Dec 31, 2022 | 16,880.00 |
| Dec 31, 2022 | 16,880.00 |
| Jun 30, 2022 | 18,844.00 |
| Jun 30, 2022 | 18,844.00 |
| Mar 31, 2022 | 21,335.00 |
| Mar 31, 2022 | 21,335.00 |
| Dec 31, 2021 | 22,929.00 |
| Dec 31, 2021 | 22,929.00 |
| Sep 30, 2021 | 23,927.00 |
| Sep 30, 2021 | 23,927.00 |
| Jun 30, 2021 | 25,546.00 |
| Jun 30, 2021 | 25,546.00 |
| Mar 31, 2021 | 26,460.00 |
| Mar 31, 2021 | 26,460.00 |
| Sep 30, 2020 | 26,674.00 |
| Sep 30, 2020 | 26,674.00 |
| Jun 30, 2020 | 26,489.00 |
| Jun 30, 2020 | 26,489.00 |
| Mar 31, 2020 | 27,566.00 |
| Mar 31, 2020 | 27,566.00 |
| Dec 31, 2019 | 30,163.00 |
| Dec 31, 2019 | 30,163.00 |
| Sep 30, 2019 | 29,147.00 |
| Sep 30, 2019 | 29,147.00 |
| Jun 30, 2019 | 31,065.00 |
| Jun 30, 2019 | 31,065.00 |
| Mar 31, 2019 | 32,867.00 |
| Mar 31, 2019 | 32,867.00 |
| Dec 31, 2018 | 32,978.00 |
| Dec 31, 2018 | 32,978.00 |
| Sep 30, 2018 | 34,839.00 |
| Sep 30, 2018 | 34,839.00 |
| Jun 30, 2018 | 36,167.00 |
| Jun 30, 2018 | 36,167.00 |
| Mar 31, 2018 | 39,638.00 |
| Mar 31, 2018 | 39,638.00 |
| Dec 31, 2017 | 39,124.00 |
| Dec 31, 2017 | 39,124.00 |
| Sep 30, 2017 | 26,200.00 |
| Sep 30, 2017 | 26,200.00 |
| Jun 30, 2017 | 31,837.00 |
| Jun 30, 2017 | 31,837.00 |
| Mar 31, 2017 | 38,917.00 |
| Mar 31, 2017 | 38,917.00 |
| Dec 31, 2016 | 39,365.00 |
| Dec 31, 2016 | 39,365.00 |
| Sep 30, 2016 | 42,594.00 |
| Sep 30, 2016 | 42,594.00 |
| Jun 30, 2016 | 45,770.00 |
| Jun 30, 2016 | 45,770.00 |
| Dec 31, 2015 | 52,483.00 |
| Dec 31, 2015 | 52,483.00 |